Niraparib synergizes BRAF-targeting agent dabrafen..

إنشاء مقالة جديدة

منذ 4 سنوات - ترجم

Niraparib synergizes BRAF-targeting agent dabrafenib to treat anaplastic hypothyroid cancer malignancy by simply suppressing AKT/hTERT signalling | #selinexor #niraparib #gefitinib (ZD1839)

Niraparib synergizes BRAF-targeting agent dabrafenib to treat anaplastic hypothyroid cancer malignancy by simply suppres

045 might be accomplished using 20% OSA. Consequently, straight line lower denseness polyethylene/starch (LLDPE/5) blends have been prepared using suc

إعجاب

علق